SEC Form 4 · accession 0001144204-18-015309
BIOLIFE SOLUTIONS INC · BLFS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael Rice
Officer — President & CEO · Director
Period of report
Mar 15, 2018
Accepted (ET)
Mar 16, 2018 · 4:30 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000834365
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 15, 2018 | M | 12,540 | $1.12 | A | 152,057 | D | |
| Common StockF2 | Mar 15, 2018 | S | 12,540 | $5.27 | D | 139,517 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock OptionF3 | $1.12 | Mar 15, 2018 | M | 12,540 | D | Aug 14, 2012 | Feb 24, 2021 | Common Stock | 12,540 | 122,947 | D |
Explanation of responses
- F1The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 14, 2017, the terms of which have been disclosed in a Form 8-K filed by BioLife Solutions, Inc. (the "Registrant") on December 14, 2017.
- F2The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.25 to $5.28, inclusive. The reporting person undertakes to provide to the Registrant, any security holder of the Registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- F3The reporting person exercised this option to purchase 12,540 shares on February 15, 2018. For more information regarding that option exercise, see the Form 4 filed by the reporting person on February 16, 2018.